| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 09/29/2009 | US7595314 Such as (2-morpholin-4-yl-5-nitro-phenyl)-[4-(5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-methanone; for treatment of psychoses, pain, neurodegenerative disfunction in memory and learning, schizophrenia, dementia, attention deficit disorders, or Alzheimer's disease |
| 09/29/2009 | CA2550372C Alpha-hydroxy amides as bradykinin antagonists or inverse agonists |
| 09/24/2009 | WO2009115644A1 Lanthanide(iii) chelates comprising beta-diketones and conjugates derived thereof |
| 09/24/2009 | US20090240056 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 09/24/2009 | US20090239865 Dibenzyl amine compounds and derivatives |
| 09/23/2009 | EP1461038B9 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 09/23/2009 | EP0946508B1 NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS |
| 09/23/2009 | CN101538193A Method for preparing compounds containing difluoromethyl |
| 09/22/2009 | US7592462 Explosive complexes |
| 09/17/2009 | WO2009112736A1 Materials for the solid/liquid extraction of heavy metal ions, containing supported n-functionalised polyazacycloalkanes |
| 09/17/2009 | DE102008056811A1 Agent, useful e.g. for oxidative coloring of keratin fibers e.g. human hair, wool and feathers, comprises substituted 4-aminophenyl compounds and/or their salt as oxidation dyestuff precursor of developer-type in a cosmetic carrier |
| 09/16/2009 | EP2099776A1 Chelating agent |
| 09/16/2009 | CN101531671A Micro-porous copper coordination polymer, preparation method and application thereof |
| 09/16/2009 | CN100540541C A process for the preparation of phenyltetrazole derivatives |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | CA2366600C A process for the preparation of 1,4,7,10-tetraazacyclododecane |
| 09/10/2009 | US20090227604 Vitamin d receptor modulators |
| 09/09/2009 | EP2097395A1 Process for the preparation of valsartan and intermediate products |
| 09/08/2009 | CA2314339C N-benzyl-3-indenylacetamide derivatives for treating neoplasia |
| 09/03/2009 | WO2009106817A2 Compound |
| 09/03/2009 | WO2009106470A2 Angiotensin ii receptor antagonists |
| 09/03/2009 | US20090221836 Process for the preparation of valsartan and precursors thereof |
| 09/03/2009 | CA2712689A1 Angiotensin ii receptor antagonists |
| 09/02/2009 | EP2094655A1 Novel biphenyl thio-urea derivatives useful as potassium channel modulators |
| 09/02/2009 | EP1926705B1 Process for preparing valsartan |
| 09/02/2009 | EP1844019B1 Methode for the production of losartan |
| 09/02/2009 | EP1472259B1 Tetrapyrrolic macrocycles as photodynamic agents |
| 09/02/2009 | CN100534987C New method for preparing 2-methoxy-5(5-trifluoromethyl-1H-tetraazo-1-group) benzaldehyde |
| 09/01/2009 | US7582647 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 09/01/2009 | CA2431206C Combination drugs containing anti-sepsis cycloalkene compound |
| 08/27/2009 | WO2009103218A1 Ethylidene hydrazine carboxamide derivatives, preparation process and pharmaceutical use thereof |
| 08/27/2009 | WO2009065059A9 Super-oxide dismutase mimetics |
| 08/27/2009 | WO2006087393A3 Structural analogues of avenanthramides, their use in compositions useful in the treatment of dermatological disorders |
| 08/27/2009 | US20090216011 Synthesis of cyclen derivatives |
| 08/27/2009 | US20090215843 Tetrazole Derivatives and Their Use for the Treatment of Cardiovascular Diseases |
| 08/27/2009 | US20090215838 Organic nitric oxide enhancing salts of angiotensin ii antagonists, compositions and methods of use |
| 08/27/2009 | US20090215825 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/27/2009 | US20090215026 Method for storing tetrazolium compound, stabilizer used in the same, and tetrazolium compound reagent solution using the method |
| 08/26/2009 | CN100532377C Compound containing tetrazine polynitrobenzene and synthesis method thereof |
| 08/25/2009 | US7579480 Producing an alkoxy(tetrazol-1-yl)benzaldehyde compound by reacting the corresponding 1-(alkoxyphenyl)-1H-tetrazole compound with hexamethylenetetramine in a sulfonic acid' solvent, followed by hydrolysis; safe, efficient process; intermediate for analgesics or anti-inflammatory agents |
| 08/25/2009 | US7579352 Retinoic acid mimetic anilides |
| 08/20/2009 | US20090208573 Novel polymorph form of irbesartan |
| 08/19/2009 | EP2090567A2 Processes for the preparation of intermediates of valsartan |
| 08/19/2009 | EP2089362A1 Metal chelates having a perfluorinated peg group, method for the production thereof, and use thereof |
| 08/19/2009 | EP2089063A2 X-ray contrast agents comprising a metal chelate and a polyhalogenated phenol, thiophenol, resorcinol, thioresorcinol or dithioresorcinol |
| 08/19/2009 | EP1786789A4 Process for preparing substituted tetrazoles from aminotetrazole |
| 08/19/2009 | CN101508681A Method of preparing high purity tetrazole ammonium salt |
| 08/19/2009 | CN100528868C Coupling reactions useful in the preparation of (1h-tetrazol-5-yl)-biphenyl derivatives |
| 08/18/2009 | US7576112 Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives |
| 08/18/2009 | CA2392030C Urea compounds having muscarinic receptor antagonist activity |
| 08/13/2009 | US20090203921 Processes for the preparation of intermediates of valsartan |
| 08/13/2009 | US20090203920 Method for isolating 5-substituted tetrazoles |
| 08/12/2009 | EP1434768B1 Enhanced substrate imaging by reversible binding to a paramagnetic complex |
| 08/12/2009 | EP1089988B1 Fluorophenyl resin compounds |
| 08/12/2009 | CN101506179A Method of dynamic nuclear polarisation (DNP) and compounds and compositions for use in the method |
| 08/11/2009 | US7572922 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 08/11/2009 | US7572816 Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders |
| 08/11/2009 | US7572753 Tetrazole fungicides |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/06/2009 | WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids |
| 08/06/2009 | US20090198056 such as N-[(1S,2R)-1-Benzyl-2-hydroxy-3-(1H-imidazol-2-ylamino)-3-oxopropyl]-5-[methyl(methylsulfonyl)amino]-N'-[(1R)-1-phenylethyl]isophthalamide, used for the for treatment of Alzheimer's disease |
| 08/06/2009 | US20090197888 Fluorinated tripeptide hcv serine protease inhibitors |
| 08/05/2009 | EP2085379A1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 08/05/2009 | EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders |
| 08/05/2009 | CN101498002A Surface-treating agent for metal and printed wiring substrate |
| 08/05/2009 | CN100522953C Synthesis method of valsartan |
| 08/05/2009 | CN100522952C Insecticidal phthalamide derivatives |
| 08/05/2009 | CN100522171C 1-benzoyl-piperazine derivatives as glycine uptake inhibitors for the treatment of psychoses |
| 08/04/2009 | CA2568104C Intermediates useful in production of antivirally active heterocyclic azahexane derivatives |
| 08/04/2009 | CA2434228C Biphenyl derivatives |
| 07/30/2009 | WO2009094242A1 Angiotensin ii receptor antagonists |
| 07/30/2009 | WO2009065081A3 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 07/30/2009 | WO2009065070A3 Prostaglandin e1 and e2 analogs for the treatment of various medical conditions |
| 07/30/2009 | US20090192318 Method of preparation of N-(1-oxopentyl)-N-[[2'-(1H-tetrazol-5-y1) [1,1'-biphenyl]-4-y1]methyl]-L-valine (valsartan) |
| 07/30/2009 | US20090192140 Iap bir domain binding compounds |
| 07/30/2009 | US20090192136 Benzoyl-piperazine derivatives |
| 07/30/2009 | CA2711134A1 Angiotensin ii receptor antagonists |
| 07/29/2009 | EP2081888A1 N-biaryl (hetero) arylsulphonamide derivatives useful in the treatment of diseases mediated by lymphocytes interactions |
| 07/28/2009 | US7566803 Vitamin D receptor modulators |
| 07/23/2009 | WO2009090903A1 Platinum complex compound and utilization of the same |
| 07/23/2009 | CA2712408A1 Platinum complex compound and utilization of the same |
| 07/23/2009 | CA2710374A1 Fungicide hydroximoyl-tetrazole derivatives |
| 07/22/2009 | EP2080756A2 Method for making losartan |
| 07/21/2009 | USRE40861 4-Trimethylammonium-3-(nonylcarbamoyl)-aminobutyrate; hypoglycemic agents; antidiabetic agents; antiischemic agents; congestive heart failure; obesity |
| 07/16/2009 | WO2009089022A1 N-alkoxyamide conjugates as imaging agents |
| 07/16/2009 | WO2009086753A1 Preparation methods of aminomethyl biphenyl tetrazole compounds and their salts, intermediates and preparation methods thereof |
| 07/16/2009 | WO2009061681A3 Antagonists of pgd2 receptors |
| 07/16/2009 | CA2711426A1 N-alkoxyamide conjugates as imaging agents |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176841 Novel 6-5 system bicyclic heterocyclic derivative and its pharmaceutical utility |
| 07/09/2009 | US20090176804 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 07/09/2009 | US20090176773 Non-Peptidic Inhibitors of AKAP/PKA Interaction |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/08/2009 | CN101479250A Tetrazole-substituted arylamides |
| 07/08/2009 | CN101475540A Preparation of Valsartan |
| 07/07/2009 | US7557220 Tetrazole based linear polymers |
| 07/07/2009 | US7557219 Methods for making 4-tetrazolyl-4-phenylpiperidine compounds |
| 07/02/2009 | WO2009049305A3 5- (2-hydroxyphenyl) tetrazoles as hsp90 inhibitors against cancer |
| 07/02/2009 | US20090170917 Acid Mimic Compounds for the Inhibition of Isoprenyl-S-Cysteinyl Methyltransferase |
| 07/02/2009 | US20090170908 Spiro compounds and pharmaceutical use thereof |